NCT06542393
- Conditions
- Anemia, Arterial Occlusive Diseases, Arteriosclerosis, +16 more
- Locations
-
- Leonardo Ohashi São Paulo, Brazil
Clinical trial condition
Hematologic Diseases
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
15,424 public trials
2,855 recruiting studies
Hematologic Diseases trial results
NCT06541444
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
- Locations
-
- Shanghai Pudong Hospital Shanghai, Shanghai Municipality, China
Recruiting
DAratumumab and REvlimid REfractory MM
NCT06541860
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Irccs San Matteo Pavia Pavia, PV, Italy
NCT06392581
- Conditions
- Acute Lymphoblastic Leukemia, Bacterial Infections and Mycoses, Hematologic Diseases, +13 more
- Locations
-
- ASST degli Spedali Civili di Brescia Brescia, Italy
Recruiting
Preoperative Hemogram Parameters and BRAF Molecular Test Detected by Bethesda 3 Cytology.
NCT06539702
- Conditions
- BRAF V600E, Blood Platelet Disorder, Blood Platelet Disorders, +14 more
- Locations
-
- Prof. Dr. Cemil Tascioglu City Hospital Istanbul, Turkey (Türkiye)
NCT06537843
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Hospital Ophir Loyola Belém, Brazil
- Hospital de Clínicas da UFPR Curitiba, Brazil
- Hospital Universitario Polydoro Ernani de Sao Thiago Florianópolis, Brazil
- Hospital Amaral Carvalho Jaú, Brazil
Recruiting
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
NCT06536959
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Xiao-ning Gao Beijing, Beijing Municipality, China
NCT06536010
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Huai'an Second People's Hospital Huai'an, Jiangsu, China
Recruiting
Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
NCT06532058
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
- Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
- The First People's Hospital of Changzhou Changzhou, Jiangsu, China
- Huai 'an First People's Hospital Huaian, Jiangsu, China
NCT06532084
- Conditions
- Acute Myeloid Leukemia, in Relapse, Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- RM Gorbacheva Research Institute Saint Petersburg, Russia